Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol ...

Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started a side hustle to afford it.

Semaglutide injections are usually prescribed on a dose escalation scheme, meaning you start low and gradually increase your dosage. The starting dose of Wegovy is typically 0.25 milligrams ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily ...